Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Alexandre C. C. Vieira, Luíse L. Chaves, Marina Pinheiro, Sofia A. Costa Lima, Domingos Ferreira, Bruno Sarmento & Salette Reis. (2018) Mannosylated solid lipid nanoparticles for the selective delivery of rifampicin to macrophages. Artificial Cells, Nanomedicine, and Biotechnology 46:sup1, pages 653-663.
Read now
Read now
Tarun Garg, Amit K. Goyal, Goutam Rath & R. S. R. Murthy. (2016) Spray-dried particles as pulmonary delivery system of anti-tubercular drugs: design, optimization, in vitro and in vivo evaluation. Pharmaceutical Development and Technology 21:8, pages 951-960.
Read now
Read now
Gurmeet Kaur, Tarun Garg, Goutam Rath & Amit K. Goyal. (2016) Archaeosomes: an excellent carrier for drug and cell delivery. Drug Delivery 23:7, pages 2497-2512.
Read now
Read now
Jagdeep Singh, Tarun Garg, Goutam Rath & Amit K. Goyal. (2016) Advances in nanotechnology-based carrier systems for targeted delivery of bioactive drug molecules with special emphasis on immunotherapy in drug resistant tuberculosis – a critical review. Drug Delivery 23:5, pages 1676-1698.
Read now
Read now
Articles from other publishers (28)
Mumuni Sumaila, Pradeep Kumar, Philemon Ubanako, Samson A. Adeyemi & Yahya E. Choonara. (2023) Dual Rifampicin and Isoniazid Mannose-Decorated Lipopolysaccharide Nanospheres for Macrophage-
Targeted Lung Delivery. Current Drug Delivery 20:10, pages 1487-1503.
Crossref
Crossref
Ayushi Nair, Alosh Greeny, Amritasree Nandan, Ranjay Kumar Sah, Anju Jose, Sathish Dyawanapelly, Vijayabhaskarreddy Junnuthula, Athira K. V.Prashant Sadanandan. (2023) Advanced drug delivery and therapeutic strategies for tuberculosis treatment. Journal of Nanobiotechnology 21:1.
Crossref
Crossref
HalaMohammedali Makki, MaiA Alim A Sattar Ahmad, HudaMohammed Alkreathy & Omar Alshargi. (2023) Therapeutic drug monitoring in optimizing tuberculosis treatment outcomes: A review on the first-line four-drug standard treatment regimen. Saudi Journal of Clinical Pharmacy 2:3, pages 66.
Crossref
Crossref
Dhaval J. Patel, Sunita Chaudhary, Ankit B. Chaudhary & Jayvadan K. Patel. 2023. Tubercular Drug Delivery Systems. Tubercular Drug Delivery Systems
123
143
.
Dhwani Rana, Sagar Salave, Ritu Patel, Dignesh Khunt, Manju Misra, Bhupendra Prajapati, Geeta Patel & Jayvadan Patel. 2023. Tubercular Drug Delivery Systems. Tubercular Drug Delivery Systems
99
121
.
Geeta Patel, Bhupendra Prajapati & Yashwant Pathak. 2023. Tubercular Drug Delivery Systems. Tubercular Drug Delivery Systems
235
260
.
Sergey V. Valiulin, Andrey A. Onischuk, Anatoly M. Baklanov, Sergey N. Dubtsov, Galina G. Dultseva, Sergey V. An’kov, Tatiana G. Tolstikova, Sergey N. Belogorodtsev & Yakov Sh. Schwartz. (2022) Studies of the Specific Activity of Aerosolized Isoniazid against Tuberculosis in a Mouse Model. Antibiotics 11:11, pages 1527.
Crossref
Crossref
Maria John Newton Amaldoss & Reeta. 2022. Micro- and Nanoengineered Gum-Based Biomaterials for Drug Delivery and Biomedical Applications. Micro- and Nanoengineered Gum-Based Biomaterials for Drug Delivery and Biomedical Applications
183
225
.
Pooja Sanjay Khairnar, Ajit Singh & Rahul Shukla. 2022. Nanotechnology for Infectious Diseases. Nanotechnology for Infectious Diseases
387
417
.
Aristote B. Buya, Bwalya A. Witika, Alain M. Bapolisi, Chiluba Mwila, Grady K. Mukubwa, Patrick B. Memvanga, Pedzisai A. Makoni & Christian I. Nkanga. (2021) Application of Lipid-Based Nanocarriers for Antitubercular Drug Delivery: A Review. Pharmaceutics 13:12, pages 2041.
Crossref
Crossref
Claudio Pettinari, Riccardo Pettinari, Corrado Di Nicola, Alessia Tombesi, Stefania Scuri & Fabio Marchetti. (2021) Antimicrobial MOFs. Coordination Chemistry Reviews 446, pages 214121.
Crossref
Crossref
Goutam Rath, Deepak Pradhan, Goutam Ghosh & Amit K. Goyal. (2021) Challenges and Opportunities of Nanotechnological based Approach for the Treatment of Tuberculosis. Current Pharmaceutical Design 27:17, pages 2026-2040.
Crossref
Crossref
Sivaraj Mehnath & Murugaraj Jeyaraj. 2021. A Mechanistic Approach to Medicines for Tuberculosis Nanotherapy. A Mechanistic Approach to Medicines for Tuberculosis Nanotherapy
59
89
.
Deepa Thomas, K. KurienThomas & M.S. Latha. (2020) Preparation and evaluation of alginate nanoparticles prepared by green method for drug delivery applications. International Journal of Biological Macromolecules 154, pages 888-895.
Crossref
Crossref
Rahul Shukla, Aakriti Sethi, Mayank Handa, Mradul Mohan, Pushpendra K. Tripathi & Prashant Kesharwani. 2020. Nanotechnology Based Approaches for Tuberculosis Treatment. Nanotechnology Based Approaches for Tuberculosis Treatment
163
174
.
S.V. Valiulin, A.A. Onischuk, A.M. Baklanov, S.N. Dubtsov, S.V. An'kov, T.G. Tolstikova, M.E. Plokhotnichenko, G.G. Dultseva & P.S. Mazunina. (2019) Excipient-free isoniazid aerosol administration in mice: Evaporation-nucleation particle generation, pulmonary delivery and body distribution. International Journal of Pharmaceutics 563, pages 101-109.
Crossref
Crossref
Gabriela Wyszogrodzka, Przemysław Dorożyński, Barbara Gil, Wieslaw J. Roth, Maciej Strzempek, Bartosz Marszałek, Władysław P. Węglarz, Elżbieta Menaszek, Weronika Strzempek & Piotr Kulinowski. (2018) Iron-Based Metal-Organic Frameworks as a Theranostic Carrier for Local Tuberculosis Therapy. Pharmaceutical Research 35:7.
Crossref
Crossref
Gujie Mi, Di Shi, Mian Wang & Thomas J. Webster. (2018) Reducing Bacterial Infections and Biofilm Formation Using Nanoparticles and Nanostructured Antibacterial Surfaces. Advanced Healthcare Materials 7:13, pages 1800103.
Crossref
Crossref
Reaz Uddin, Quratulain Nehal Siddiqui, Syed Sikander Azam, Bibi Saima & Abdul Wadood. (2018) Identification and characterization of potential druggable targets among hypothetical proteins of extensively drug resistant Mycobacterium tuberculosis (XDR KZN 605) through subtractive genomics approach. European Journal of Pharmaceutical Sciences 114, pages 13-23.
Crossref
Crossref
Sinosh Skariyachan & Shruthi Garka. 2018. Fullerens, Graphenes and Nanotubes. Fullerens, Graphenes and Nanotubes
1
29
.
Arunachalam Muthuraman, Narahari Rishitha & Seema Mehdi. 2018. Design of Nanostructures for Theranostics Applications. Design of Nanostructures for Theranostics Applications
529
562
.
Susana Rodrigues, Ana D. Alves, Joana S. Cavaco, Jorge F. Pontes, Filipa Guerreiro, Ana M. Rosa da Costa, Francesca Buttini & Ana Grenha. (2017) Dual antibiotherapy of tuberculosis mediated by inhalable locust bean gum microparticles. International Journal of Pharmaceutics 529:1-2, pages 433-441.
Crossref
Crossref
Sadeque H. Mithu, Syed N. Haque, Babur Z. Chowdhry, Ali Nokhodchi & Mohammed Maniruzzaman. (2017) RETRACTED: Evaluation of the surface chemistry and drug-polymer interaction of semi-crystalline micro-particles for the development of controlled release formulations. Materials Science and Engineering: C 76, pages 559-567.
Crossref
Crossref
Rajendran Amarnath Praphakar, Murugan A. Munusamy & Mariappan Rajan. (2017) Development of extended-voyaging anti-oxidant Linked Amphiphilic Polymeric Nanomicelles for Anti-Tuberculosis Drug Delivery. International Journal of Pharmaceutics 524:1-2, pages 168-177.
Crossref
Crossref
Raúl Garza-Velasco, Jacqueline Ávila-de Jesús & Luis Manuel Perea-Mejía. (2017) Tuberculosis pulmonar: la epidemia mundial continúa y la enseñanza de este tema resulta crucial y compleja. Educación Química 28:1, pages 38-43.
Crossref
Crossref
Amit K. Goyal, Tarun Garg, Sourav Bhandari & Goutam Rath. 2017. Nanostructures for Drug Delivery. Nanostructures for Drug Delivery
669
695
.
Nazende Günday Türeli, Akif E. Türeli & Marc Schneider. (2016) Counter-ion complexes for enhanced drug loading in nanocarriers: Proof-of-concept and beyond. International Journal of Pharmaceutics 511:2, pages 994-1001.
Crossref
Crossref
Amit Kumar Goyal, Tarun Garg, Goutam Rath, Umesh Datta Gupta & Pushpa Gupta. (2015) Development and Characterization of Nanoembedded Microparticles for Pulmonary Delivery of Antitubercular Drugs against Experimental Tuberculosis. Molecular Pharmaceutics 12:11, pages 3839-3850.
Crossref
Crossref